MedBright AI Investments Inc. - MBAIF STOCK NEWS

Welcome to our dedicated news page for MedBright AI Investments (Ticker: MBAIF), a resource for investors and traders seeking the latest updates and insights on MedBright AI Investments.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MedBright AI Investments's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MedBright AI Investments's position in the market.

01/09/2024 07:00 AM

News

MedBright AI Announces Rejuvenation Medical Group, a Large Canadian Clinic Group, as First International Customer for MedMatrix, the AI-Driven Data and Analytics Platform

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) is pleased to announce that Rejuvenation medical group, a prominent dermatology group in Canada, has decided to adopt MedMatrix, an AI-powered data analytics platform, across all its 9 clinics. Rejuvenation medical group caters to over 750,000 patients each year and has a highly skilled team comprising 21 dermatologists, 5 Mohs surgeons, 2 plastic surgeons, and 13 general practitioners. MedMatrix aims to enhance their already formidable healthcare offerings through advanced AI and data analytics capabilities.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.25%

Tags

01/04/2024 08:00 AM

News

MedBright AI Appoints Trevor Vieweg as Chief Executive Officer

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) announces the appointment of Trevor Vieweg as CEO and an investor relations agreement with Outside the Box Capital Inc. The new CEO brings extensive AI and commercial expertise from his previous roles. The company aims to monetize AI investment opportunities in the healthcare sector. The investor relations agreement includes social media engagement services and the grant of 400,000 incentive stock options.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

17.06%

Tags

12/28/2023 04:30 PM

News

MedBright AI Announces Closing of Investment in Limmi Healthcare AI Platform

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) announces the issuance of 350 common shares of MB Acquisition Co. to Limmi pursuant to an intellectual property license and option agreement. Limmi granted certain rights to the Limmi AI Platform in exchange for the MBAC Shares, subject to specific conditions and an option for MB Licensing Co. to purchase the platform. MedBright also created a new class of non-voting common shares, the MedBright Class A Shares, and agreed to pay an arm's length finder 1,000,000 Common Shares.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-3.14%

Tags

12/14/2023 08:00 AM

News

MedBright AI Announces CareMEDICA, a Yale University School of Medicine Affiliated Clinic Group, as Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) announced that CareMEDICA, a leading clinic group in Connecticut and South Florida, has chosen to implement the beta version of MedMatrix, an AI-powered data analytics platform, into its practice. CareMEDICA, affiliated with Yale University School of Medicine and Quinnipiac University Medical Program, aims to optimize clinic operations and improve patient outcomes through the use of AI technology.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

3.08%

Tags

12/12/2023 07:07 AM

News

Emerging Markets Report: Building Trust

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) has been making significant moves, including a name change to MedBright, supporting medical economics lectures at Yale University School of Medicine, appointing highly qualified board members, and launching MedMatrix, an AI-powered data analytics platform. The company seems focused on acquiring customers and maintaining transparency, signaling a positive business outlook.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

8.02%

Tags

12/07/2023 08:00 AM

News

MedBright AI Announces Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) is pleased to announce that the Dermatology Institute & Skin Care Center (DISCC) in Southern California has chosen to implement MedMatrix, an AI-powered data analytics platform developed by Healthcare Accretion AI, to improve their clinic operations.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-7.09%

Tags

12/05/2023 08:00 AM

News

MedBright AI Announces Election of Two US Healthcare Experts to Board of Directors and Approval of New Share Class

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) welcomes Dr. Jaime Gerber and Dr. Konita Wilks as new board members. Dr. Gerber, a cardiologist and Professor of Medicine at Yale, will serve as Chairman of the Board. Dr. Wilks, a CEO with over 25 years of experience in healthcare and the military, brings valuable expertise. The shareholders have also approved the creation of a new class of Class 'A' non-voting common shares in connection with the Company’s transaction with an FDA & HIPPA compliant Artificial Intelligence Platform 'AIP' doing business as Limmi, a Delaware corporation named Mentorhead Incorporated.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-4.96%

Tags

11/29/2023 08:00 AM

News

MedBright AI Unveils New Investment Presentation Announcing MedMatrix, the AI-Driven Data Analytics and Improvement Platform

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) announces the release of a new investment presentation focusing on MedMatrix, an AI-powered data analytics platform developed by Healthcare Accretion AI. The presentation highlights how MedMatrix aims to improve healthcare operations by empowering doctors and operators to enhance clinic revenue, reduce physician burnout, and improve patient satisfaction.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

11.13%

Tags

11/22/2023 09:00 AM

News

MedBright AI Investments and The Ken Sperling Lecture Series Support Medical Economics Lectures at Yale University Medical School

Rhea-AI Summary

MedBright AI Investments Inc. (MBAI) partners with The Ken Sperling Lecture Series to support medical economics lectures at Yale University School of Medicine. The series, founded in honor of Ken Sperling, focuses on healthcare economics in the US, including the impact of AI on healthcare services.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-4.19%

Tags

11/21/2023 07:07 AM

News

Emerging Markets Report: Meeting the Moment

Rhea-AI Summary

MedBright AI Investments Inc. (MBAIF) formerly known as Vinergy Capital Inc. has rebranded to align with its focus on AI-driven healthcare technologies and investments. The company aims to seize market share in the highly lucrative AI in healthcare market, which is projected to reach USD 280.77 Billion by 2032. Recent strategic hires and investments in FDA and HIPAA compliant AI platforms indicate the company's rapid expansion and improvement in pursuing this opportunity.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-7.22%

Tags